Literature DB >> 33224856

Indian experience of AUS/FLUS diagnosis: is it different from rest of Asia and the West?-A systematic review and meta-analysis.

Prerna Guleria1, Kalaivani Mani2, Shipra Agarwal3.   

Abstract

BACKGROUND: Atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) is the most heterogeneous subcategory of the Bethesda system for thyroid cytopathology with laid down permissible limits of frequency and risk of malignancy (ROM). Due to differences in thyroid clinical practice worldwide, variations have been found in frequency, resection rates (RR) and ROM. Therefore, this systematic review and meta-analysis of AUS/FLUS across different regions was conducted and comparison of data from India was done with the rest of Asia and the West.
METHODS: We searched PubMed and Google search engines from January 2009-Dec 2019 using terms "AUS Thyroid" and "FLUS Thyroid". Meta-analysis was performed using DerSimonian-Laird method and 95% confidence intervals were calculated using random effects model. Independent samples t-test was used to compare frequency, RR, and ROM of AUS/FLUS between India, rest of Asia and the West.
RESULTS: Out of 15,000 studies on internet, 60 (18 Indian, 12 Asian and 30 Western) were included. Total aspirates were 201,657; 14,279 Indian, 62,448 Asian, 124,930 Western. Pooled estimates were: frequency 7.3% (6.3-8.3%), RR 41.9% (37.4-46.6%), ROM 33.3% (26.8-39.9%). Pooled prevalence of rate did not vary significantly across the three regions. Pooled prevalence of RR was highest in India (52.9%) and lowest in rest of Asia (26.5%); of ROM was highest in Asia (45.9%), lowest in the West (26.3%) (P<0.01). Statistical analysis demonstrated publication bias, limited to Indian and Western studies. Papillary thyroid carcinoma was the most common surgical diagnosis (87.9%; 1,082/1,231).
CONCLUSIONS: This meta-analysis showed differences in thyroid clinical practice followed in India, rest of Asia and the West. Although pooled prevalence of rate of AUS/FLUS was similar across the three, pooled RR and ROM varied. AUS/FLUS nodules were more frequently resected in Indian and Western studies than in rest of Asia. ROM was higher than recommended values in all three areas, being intermediate for India. 2020 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Atypia of undetermined significance/follicular lesion of undetermined significance thyroid (AUS/FLUS thyroid); Indian; meta-analysis; resection rate (RR); risk of malignancy (ROM)

Year:  2020        PMID: 33224856      PMCID: PMC7667083          DOI: 10.21037/gs-20-392

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  75 in total

1.  Application of the Bethesda System for Reporting Thyroid Cytopathology in the Eastern Province of Saudi Arabia: A Follow-Up Study.

Authors:  Noof A Alabdulqader; Sameera Q Shareef; Jassim A Ali; Mohammad M Yousef; Mousa A Al-Abbadi
Journal:  Acta Cytol       Date:  2015-05-30       Impact factor: 2.319

2.  Interobserver and intraobserver variation in the morphological evaluation of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice.

Authors:  Zhiyan Liu; Andrey Bychkov; Chan Kwon Jung; Mitsuyoshi Hirokawa; Shaofeng Sui; SoonWon Hong; Chiung-Ru Lai; Deepali Jain; Sule Canberk; Kennichi Kakudo
Journal:  Pathol Int       Date:  2019-02-27       Impact factor: 2.534

3.  Low Rate of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in Asian Practice.

Authors:  Andrey Bychkov; Mitsuyoshi Hirokawa; Chan Kwon Jung; Zhiyan Liu; Yun Zhu; Soon Won Hong; Shinya Satoh; Chiung-Ru Lai; Lien Huynh; Kennichi Kakudo
Journal:  Thyroid       Date:  2017-06-05       Impact factor: 6.568

4.  Comparison of 5-tiered and 6-tiered diagnostic systems for the reporting of thyroid cytopathology: a multi-institutional study.

Authors:  Massimo Bongiovanni; Stefano Crippa; Zubair Baloch; Simonetta Piana; Alessandra Spitale; Fabio Pagni; Luca Mazzucchelli; Camillo Di Bella; William Faquin
Journal:  Cancer Cytopathol       Date:  2011-10-13       Impact factor: 5.284

5.  Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation.

Authors:  Leila Yassa; Edmund S Cibas; Carol B Benson; Mary C Frates; Peter M Doubilet; Atul A Gawande; Francis D Moore; Brian W Kim; Vânia Nosé; Ellen Marqusee; P Reed Larsen; Erik K Alexander
Journal:  Cancer       Date:  2007-12-25       Impact factor: 6.860

6.  The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference.

Authors:  Ritu Nayar; Marina Ivanovic
Journal:  Cancer       Date:  2009-06-25       Impact factor: 6.860

7.  Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations.

Authors:  Jack Yang; Vicki Schnadig; Roberto Logrono; Patricia G Wasserman
Journal:  Cancer       Date:  2007-10-25       Impact factor: 6.860

8.  Evaluation of thyroid nodules classified as Bethesda category III on FNAC.

Authors:  Shiwani Garg; Leena P Naik; Kanchan S Kothari; Gwendolyn C Fernandes; Mona A Agnihotri; Jagruti C Gokhale
Journal:  J Cytol       Date:  2017 Jan-Mar       Impact factor: 1.000

9.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

Review 10.  Thyroid Cytology: The Japanese System and Experience at Yamashita Thyroid Hospital.

Authors:  Shinya Satoh; Hiroyuki Yamashita; Kennichi Kakudo
Journal:  J Pathol Transl Med       Date:  2017-10-11
View more
  1 in total

1.  Correlation between Thyroid Imaging Reporting and Data System and Bethesda System of Reporting of Thyroid Cytopathology of Thyroid Nodule: A Single Center Experience.

Authors:  Ananya Biswas; Keya Basu; Suparna De; Subhrajyoti Karmakar; Debanu De; Moumita Sengupta; Sujoy Ghosh
Journal:  J Cytol       Date:  2020-09-16       Impact factor: 1.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.